Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Costs and economics

Topic: Health services, long-term care and technology

Background Survey-based estimates of disease prevalence may be affected by non-response. To assess the extent to which incomplete participation may distort prevalence estimates, we compared diagnosis prevalences among survey participants with those in the total sample Methods A total of 26,000 insurees of the German statutory health insurance fund BARMER were selected and invited to participate in a health survey. After few exclusions, the analytic total sample comprised 25,977 individuals, of whom 7,087 participated. Raw and population standardized/weighted diagnosis prevalences were estimated for both survey participants and the total sample based on health claims data. Results Differences between survey participants and the total sample were observed across ICD chapters, ICD groups, and selected diagnoses. In most instances, prevalence estimates were higher among participants than in the total sample. Mental and behavioural disorders represented the main exception, with lower prevalence estimates among participants. After weighting for sex, age, and region of residence, differences were generally small at the aggregate level, although notable deviations remained for some mental disorders and for dementia. Conclusion In this setting, selective participation had only a limited effect on prevalence estimates after weighting. These findings suggest that, despite a modest response rate, survey-based prevalence estimates for many common diagnoses may be more robust than often assumed. At the same time, diagnosis-specific non-response bias remains relevant for some mental disorders and vulnerable subgroups.

Key findings

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 20 of the 62 points it could be judged on, which is 32 of 100. Raw total 32 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 32 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 32 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, effect reported and randomised / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 20 of the 62 points we could judge it on, which is 32 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (Research Square)
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 25,977 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 20 / 62 Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 20 of the 62 points we could judge it on is 32 out of 100.
Total 32 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Frerk, T., Vogelgesang, F., Thamm, R., Julia, T., Joachim, S., Schumacher, C., et al. (2026). How Much Non-response Matters? Diagnosis Prevalence Estimates in Survey Participants Versus the Total Sample. Research Square. https://doi.org/10.21203/rs.3.rs-10216874/v1

Vancouver

Frerk T, Vogelgesang F, Thamm R, Julia T, Joachim S, Schumacher C, et al. How Much Non-response Matters? Diagnosis Prevalence Estimates in Survey Participants Versus the Total Sample. Research Square. 2026. doi:10.21203/rs.3.rs-10216874/v1.

BibTeX

@article{frerk2026-033fcf76,
  author  = {Frerk, T. and Vogelgesang, F. and Thamm, R. and Julia, T. and Joachim, S. and Schumacher, C. and Marschall, U. and Grobe, T. G.},
  title   = {{How Much Non-response Matters? Diagnosis Prevalence Estimates in Survey Participants Versus the Total Sample}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10216874/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10216874/v1}
}

Related studies in Costs and economics

Similar studies

More on Costs and economics

See all studies in Costs and economics →